Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis Pigmentosa

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

January 30, 2018

Conditions
Retinitis Pigmentosa
Interventions
BIOLOGICAL

Platelet rich plasma

blood is drawn from the patient's antecubital vein and inserted into four 3.0 ml vacutainer tubes that contain trisodium citrate. These four tubes were placed in a centrifuge machine, and centrifugation was carried out at 2500 rpm (580×g) for 8 min within a 30-min blood collection period. As a result of centrifugation, the plasma was separated in the vacutainer tubes from the remaining blood components. Three different layers formed in the tubes: red blood cells at the bottom, aPRP in the middle layer, and aPPP in the top layer. A total of 1.5 ml of the middle layer (which mainly contained platelets) was withdrawn by syringe, and it was immediately injected into the subtenon space of each eye.

Trial Locations (1)

06312

Ankara University Biotechnology Institute, Ankara

All Listed Sponsors
lead

Ankara Universitesi Teknokent

OTHER

NCT04238858 - Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis Pigmentosa | Biotech Hunter | Biotech Hunter